CST3 Gene Cerebral Amyloid Angiopathy NGS Genetic DNA Test
The CST3 Gene Cerebral Amyloid Angiopathy NGS Genetic DNA Test is an advanced diagnostic tool that plays a crucial role in the understanding and management of neurological disorders. This test utilizes Next-Generation Sequencing (NGS) technology to analyze the CST3 gene, which is linked to cerebral amyloid angiopathy (CAA). CAA is a condition characterized by the accumulation of amyloid protein in the walls of the brain’s blood vessels, leading to various neurological complications.
What the Test Measures
This genetic test detects mutations in the CST3 gene. Identifying these mutations can help in assessing an individual’s risk for developing CAA and related neurological conditions.
Who Should Consider This Test?
This test is particularly recommended for individuals who:
- Have a family history of cerebral amyloid angiopathy or related neurological disorders.
- Experience symptoms such as recurrent headaches, cognitive decline, or unexplained neurological issues.
- Are at risk due to genetic predisposition.
Benefits of Taking the Test
By undergoing the CST3 Gene Cerebral Amyloid Angiopathy NGS Genetic DNA Test, patients can:
- Gain insights into their genetic risk for neurological disorders.
- Make informed decisions regarding their health and lifestyle.
- Access targeted prevention strategies and potential treatments.
Understanding Your Results
Results from the CST3 Gene test will indicate whether any mutations are present. A genetic counselor will assist in interpreting these results, providing guidance on the implications for health and family planning.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| CST3 Gene Cerebral Amyloid Angiopathy NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Book Your Test Today!
Don’t wait to take charge of your health. Book the CST3 Gene Cerebral Amyloid Angiopathy NGS Genetic DNA Test today! For appointments, call or WhatsApp us at +2348077798758.
Turnaround time for results is approximately 3 to 4 weeks. The sample type required is blood or extracted DNA, or one drop of blood on an FTA card. Prior to the test, a genetic counseling session is recommended to gather a clinical history and create a pedigree chart of family members affected by CST3 gene conditions.
